Skip to main content
Fig. 2 | BMC Nephrology

Fig. 2

From: A retrospective study of end-stage kidney disease patients on maintenance hemodialysis with renal osteodystrophy-associated fragility fractures

Fig. 2

Mineral-bone metabolism disorders parameters between FF and CG. a: iPTH in FF and CG, *: p< 0.05 when compared with CG. b: Alkaline phosphatase in FF and CG, *: p< 0.05 when compared with CG. c: The calcium-phosphorus product in FF and CG. d: The serum phosphorus, correct calcium, serum calcium in FF and CG, *: p< 0.05 when compared with CG

Back to article page